Premedication with a novel cleansing solution containing simethicone, N-acetylcysteine and acetic acid improves visualization during upper GI endoscopy: a double-blind, multicenter, randomized controlled trial
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S28-S29
DOI: 10.1055/s-0044-1782744 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. Manno und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Esophagogastroduodenoscopy (EGDS) is the gold standard examination for upper GI disease diagnosis. Intraluminal presence of bubbles and mucus may reduce visibility and potentially impair lesion detection. It has been shown that the administration of mucolytic and tensioactive agents before EGDS can improve gastric visualization. Hence, we performed a randomized controlled trial (RCT) testing the effect of premedication with a novel solution containing simethicone, N-acetylcysteine and acetic acid on whole upper GI tract visualization.
Methods
We conducted a multicenter, prospective, double-blind RCT on consecutive adult outpatients undergoing EGDS. Between December 2022 and November 2023, patients were randomized 1:1 to drink a 50 ml cleansing solution containing simethicone 150 mg, N-acetylcysteine 250 mg and 10% acetic acid (Lumevis, Biofarmatec srl, Palermo, Italy) 30 minutes before the EGDS or to fasting only. The primary outcome was vision quality (VQ) in the whole upper GI tract, defined as the sum of 1-10 visual analogic scale (VAS, 0=no visualization – 10=perfect visualization of the mucosa) scores for each segment (esophagus, stomach and duodenum) before washing. Secondary outcomes included VQ in each upper GI segment, EGDS duration and adverse event rate Results A total of 120 patients were enrolled and randomized to cleansing solution (n=60) or fasting only (n=60). Patients' characteristics are shown in Table 1. Administration of the cleansing solution before EGDS was associated with a significantly (p=0.001) higher VQ in the whole upper GI tract compared to no intervention (median VAS score 23 [range 21-25] vs 19 [range 16-23], respectively). Regarding each upper GI segment, cleansing solution premedication was associated with a significantly higher VQ compared to fasting only both for the stomach (p=0.001, median VAS score 7 [range 6-8] vs 5 [range 4-7], respectively) and the duodenum (p=0.001, median VAS score 9 [range 8-10] vs 7 [range 5-9], respectively), but not for the esophagus (p=0.130, median VAS score 7 [range 6-9] vs 7 [range 6-8], respectively). No significant difference was observed in EGDS duration between the cleansing solution and fasting only (p=0.272, 6.1 vs 6.5 minutes, respectively), and no adverse events were reported in both groups.
Conclusions
Compared to fasting only, the administration of a novel cleansing solution containing simethicone, N-acetylcysteine and acetic acid before EGDS was associated with overall improved mucosal visualization of the upper GI tract. Our RCT results suggest that cleansing solution premedication improves quality and potentially diagnostic yield of EGDS. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Manno, M., Gibiino, G., Gualandi, N., Secco, M., Soriani, P., Cucchetti, A., Zadro, V., Binda, C., Biancheri, P., & Fabbri, C. (2024). Premedication with a novel cleansing solution containing simethicone, N-acetylcysteine and acetic acid improves visualization during upper GI endoscopy: a double-blind, multicenter, randomized controlled trial. Endoscopy, 56(S 02 S 02), S28-S29. https://doi.org/10.1055/s-0044-1782744
Vancouver
Manno M, Gibiino G, Gualandi N, Secco M, Soriani P, Cucchetti A, et al. Premedication with a novel cleansing solution containing simethicone, N-acetylcysteine and acetic acid improves visualization during upper GI endoscopy: a double-blind, multicenter, randomized controlled trial. Endoscopy. 2024;56(S 02 S 02):S28-S29. doi:10.1055/s-0044-1782744
BibTeX
@article{Manno2024,
author = {Manno, M. and Gibiino, G. and Gualandi, N. and Secco, M. and Soriani, P. and Cucchetti, A. and Zadro, V. and Binda, C. and Biancheri, P. and Fabbri, C.},
title = {Premedication with a novel cleansing solution containing simethicone, N-acetylcysteine and acetic acid improves visualization during upper GI endoscopy: a double-blind, multicenter, randomized controlled trial},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S28--S29},
doi = {10.1055/s-0044-1782744}
}
EUVIMED